1409PAssociation of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs).

Autor: Melia, M Riudavets¹ (AUTHOR), Sullivan, I Gabriela¹ (AUTHOR), Joaquín, A Barba¹ (AUTHOR), Palacios, G Anguera¹ (AUTHOR), Carpio, L P del¹ (AUTHOR), Valiente, C Molto¹ (AUTHOR), Arellano, S D Camacho¹ (AUTHOR), Asensio, S Moron¹ (AUTHOR), Pons, P Gomila¹ (AUTHOR), Granyó, M Andres¹ (AUTHOR)

Publikováno v: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.